The estimated Net Worth of Michael J. Mc Breen is at least $1.43 Millón dollars as of 7 March 2023. Mr. Breen owns over 1,843 units of Integra Lifesciences Corp stock worth over $506,810 and over the last 4 years he sold IART stock worth over $922,942. In addition, he makes $0 as Executive Vice President and President - Codman Specialty Surgical at Integra Lifesciences Corp.
Michael has made over 5 trades of the Integra Lifesciences Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 1,843 units of IART stock worth $100,056 on 7 March 2023.
The largest trade he's ever made was selling 4,000 units of Integra Lifesciences Corp stock on 6 August 2021 worth over $284,880. On average, Michael trades about 700 units every 42 days since 2020. As of 7 March 2023 he still owns at least 28,796 units of Integra Lifesciences Corp stock.
You can see the complete history of Mr. Breen stock trades at the bottom of the page.
Michael McBreen has been appointed as Executive Vice President and President - Codman Specialty Surgical of the Company effective 6/8/2020. Mr. McBreen joined Integra as part of the Codman Neurosurgery acquisition from Johnson & Johnson in 2017 as the leader of the international business. Prior to Integra, he led U.S. commercial and global marketing for Codman Neurosurgery and Neurovascular businesses and was also worldwide vice president for professional education for the Johnson & Johnson Medical Device and Diagnostics Sector. Mr. McBreen also held numerous U.S. and global roles of increasing responsibility in sales and marketing at DePuy Mitek Sports Medicine, a division of Johnson & Johnson, since joining the company in 1996.
Michael's mailing address filed with the SEC is 1100 CAMPUS ROAD, , PRINCETON, NJ, 08540.
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig y George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: